Roche
fachportal.roche.de12
Critical
Total Scans
1
Critical
1
12
12
Apr 20, 2026
0%
33%
3
1.3x
Roche’s low visibility (12/100) stems from a 0% mention rate in key German oncology and neurology AI searches. While AI cites Roche’s site (33%), it fails to name the brand, instead recommending Novartis and Pfizer for medical education. Roche is invisible in oncology portal listings but maintains indirect relevance through product-level mentions like Ocrelizumab in MS therapy.
| Date | Score | Rating | View |
|---|---|---|---|
Apr 20, 2026 | 12 | Critical | View Details |
Run a comprehensive AI Brand Audit to get actionable recommendations.
